Our Methodology
A rigorous 18-category assessment validated against real investment outcomes. We catch what others miss.
Framework Overview
Each domain covers critical aspects of medical device viability, scored by specialists with direct industry experience.
Clinical validation, FDA pathway, adoption potential, and post-market risk.
IP landscape, design maturity, manufacturing scalability, and supply chain.
Market validation, competitive positioning, reimbursement, and pricing.
Management capability, capital efficiency, runway, and milestones.
Led by Dr. Ravinutala (MD) — 5 categories
Strength of clinical evidence supporting efficacy and safety.
Clarity of FDA strategy and predicate selection.
Track record with FDA including warning letters, recalls.
Likelihood physicians will actually use the device.
Potential for adverse events, recalls, or safety signals.
Led by Aswini Ravinutala (BME) — 5 categories
Patent portfolio strength and freedom to operate.
Development stage and remaining technical risks.
Ability to scale from prototype to volume production.
Component availability and supplier concentration risk.
QMS maturity, CAPA history, and audit readiness.
Joint MD + BME Analysis — 4 categories
TAM/SAM/SOM credibility and demand signals.
Differentiation sustainability and market timing.
Payer pathway and coverage likelihood.
Price point sustainability and margin structure.
Joint MD + BME Analysis — 4 categories
Relevant experience and execution track record.
Strategic value of board and advisor network.
Burn rate and milestone achievement per dollar.
Assumption credibility and path to profitability.
How We Deliver
From intake to final recommendation in 2-3 weeks.
Define evaluation criteria aligned with your thesis.
Dr. Ravinutala evaluates clinical utility and adoption.
Aswini analyzes design, manufacturing, and IP.
Unified Vantage Score with recommendation.
Scoring System
Each category scored 1-10 with supporting evidence. The overall Vantage Score provides clear investment guidance:
See how the Vantage Score can de-risk your next medical device investment.
Schedule Consultation